STOCK TITAN
  1. Home
  2. Sec-filings
  3. IMAX
  4. [Form 4] IMAX CORP Insider Trading Activity

CEO of IMAX (IMAX) sells 135K shares after option exercise

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

IMAX CORP Chief Executive Officer Richard L. Gelfond converted stock options into 135,046 common shares at $31.40 per share and then sold the same 135,046 shares in open-market transactions at an average of $37.8158 per share, pursuant to a Rule 10b5-1 trading plan dated December 9, 2025.

Following these transactions, he directly holds 765,002 common shares and retains 1,537,045 outstanding stock options and 231,562 restricted share units, indicating a substantial remaining equity position in IMAX.

Positive

  • None.

Negative

  • None.
Insider GELFOND RICHARD L
Role Chief Executive Officer
Sold 135,046 shs ($5.11M)
Type Security Shares Price Value
Conversion stock options (to buy) 135,046 $31.40 $4.24M
Conversion common shares 135,046 $31.40 $4.24M
Sale common shares 135,046 $37.8158 $5.11M
holding common shares (opening balance) -- -- --
Holdings After Transaction: stock options (to buy) — 1,537,045 shares (Direct); common shares — 900,048 shares (Direct); common shares (opening balance) — 765,002 shares (Direct)
Footnotes (1)
  1. Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025. These options were issued in 2016 and are set to expire on June 7, 2026. The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,537,045, 231,562 and 765,002, respectively.
Options converted 135,046 shares Stock options converted into common shares on April 10, 2026
Option exercise price $31.40/share Conversion of stock options into common shares
Sale price $37.8158/share Open-market sale of 135,046 common shares
Shares sold 135,046 shares Open-market sale on April 10, 2026
Post-transaction common shares 765,002 shares Direct common share holdings after the transactions
Remaining stock options 1,537,045 options Aggregate outstanding options after these transactions
Remaining RSUs 231,562 units Restricted share unit balance after these transactions
Rule 10b5-1 Plan financial
"conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025"
A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.
stock options financial
"Represents the conversion upon exercise of stock options into common shares"
Stock options are agreements that give a person the right to buy or sell a company's stock at a specific price within a certain time frame. They are often used as a reward or incentive, similar to a coupon that can be used later if the stock price rises, allowing the holder to make a profit.
derivative security financial
"transaction_code_description: Conversion of derivative security"
A derivative security is a financial contract whose value comes from the price or performance of something else, such as a stock, bond, commodity, or market index. For investors it acts like an insurance policy or a wager: it can be used to protect against losses, lock in prices, or amplify gains and losses, so it can change a portfolio’s risk and potential return without owning the underlying asset directly.
restricted share unit financial
"remaining outstanding option, restricted share unit and common share balances"
A restricted share unit (RSU) is a promise by a company to give an employee a set number of company shares at a future date, typically after meeting time or performance conditions. For investors, RSUs matter because when they convert into actual shares they increase the number of shares outstanding (like unlocking more tickets in a game), which can dilute existing holders, and they align employee incentives with company performance, influencing behavior and long-term value.
open-market sale financial
"Sale in open market or private transaction"
An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.
Form 4 Insider Transactions: What Each Field Means →
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
GELFOND RICHARD L
(Last)(First)(Middle)
902 BROADWAY
20TH FLOOR
(Street)
NEW YORK NEW YORK 10010-6002
(City)(State)(Zip)
UNITED STATES
(Country)		2. Issuer Name and Ticker or Trading Symbol
IMAX CORP [ IMAX ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
04/10/2026		6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
common shares (opening balance)765,002D
common shares04/10/2026C135,046(1)A$31.4900,048D
common shares04/10/2026S135,046D$37.8158765,002D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
stock options (to buy)(2)$31.404/10/2026C135,046 (3)06/07/2026common shares135,046$31.41,537,045(4)D
Explanation of Responses:
1. Represents the conversion upon exercise of stock options into common shares pursuant to a 10b5-1 Plan dated December 9, 2025.
2. These options were issued in 2016 and are set to expire on June 7, 2026.
3. The stock options became exercisable in three installments: 162,095 on each of June 7, 2016 and September 1, 2016 and 162,094 on December 31, 2016.
4. This represents the number of common shares for this transaction only. Mr. Gelfond's aggregate remaining outstanding option, restricted share unit and common share balances following these transactions will be 1,537,045, 231,562 and 765,002, respectively.
Remarks:
/s/ Richard L. Gelfond04/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What did IMAX (IMAX) CEO Richard Gelfond report in this Form 4?

IMAX CEO Richard Gelfond reported converting stock options into 135,046 common shares, then selling those 135,046 shares in open-market transactions. The activity reflects an exercise-and-sell pattern, with the option conversion price at $31.40 and the sale price averaging $37.8158 per share.

How many IMAX (IMAX) shares did the CEO sell and at what price?

Richard Gelfond sold 135,046 IMAX common shares in open-market transactions at an average price of $37.8158 per share. These shares came from converting stock options that were exercisable at $31.40 per share on the same date, creating a single economic exercise-and-sale event.

What options did the IMAX (IMAX) CEO exercise in this transaction?

He converted 135,046 stock options into common shares at an exercise price of $31.40 per share. Footnotes state these options were originally issued in 2016, became exercisable in three 2016 installments, and were scheduled to expire on June 7, 2026 before this conversion.

Was the IMAX (IMAX) CEO’s sale made under a Rule 10b5-1 trading plan?

Yes. The option conversion into common shares occurred pursuant to a Rule 10b5-1 Plan dated December 9, 2025. Such pre-arranged plans are established in advance and are designed to allow executives to trade shares on a scheduled basis, independent of later information.

How many IMAX (IMAX) shares does the CEO hold after these trades?

After the reported transactions, Richard Gelfond directly holds 765,002 IMAX common shares. Footnotes also indicate he retains 1,537,045 outstanding stock options and 231,562 restricted share units, showing he still has a large overall equity stake tied to IMAX’s future performance.

How significant is this IMAX (IMAX) Form 4 transaction for investors?

The filing shows a routine exercise-and-sell pattern, with 135,046 options converted then sold. Because Gelfond continues to hold 765,002 common shares plus sizable option and restricted share unit balances, the transaction appears more like scheduled liquidity than a complete reduction of his IMAX exposure.